±í¹ÛÓÍË®·ÖÅäϵÊý,apparent oil/water partition coefficientÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÕ±¾´ó¶ú°×ÍÃ,Japanese white rabbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ÇÜÐÎ÷ÁÖÄÆ,Sulbenicillin sodiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ôȼ׻ùħÓó½º,carboxymethyl konjac glucomannanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·úÂÈÎ÷ÁÖÄÆ,flucloxacillin sodiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½Ìѧ̽Ë÷,Teaching explorationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ºÊÍĤ,slow-release membraneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°¢ÆæÃ¹ËؽºÄÒ,azithromycin capsuleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶þ¼×»ù°±ÂÈßÁßä,Dimethyl amilorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
KBϸ°û,KB cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÉ«ËØP4503A,CYP3AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·¨ÄªÌæ¶¡×¢ÉäÒº,Famotidine InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©Æ·Êг¡,Pharmaceutical marketÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹Õæ¾úÒ©ÎïÃô¸ÐÐÔÊÔÑé,antifungal susceptibility testingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ҽԺҩѧÐÅϢϵͳ,hospital pharmacy information systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ͬÐͰëë×°±ËáÁòÄÚõ¥,Homocysteine thiolactoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
MTT·ÖÎö·¨,MTT assayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©Îï¶¾Àíѧ,Drug ToxicologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáÄÉÃÀ·Ò,nalmefene hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÀÒ°±ËáøÒÖÖÆ¼Á,tyrosinase inhibitorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Ê²ÝËáµ¥ï§,monoammonium glycyrrhizinateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´×ËáÀà,Acetic acidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹¹ýÃôÒ©,Antiallergic drugsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·¢ÏÖ¶¾Àíѧ,discovery toxicologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎüÊÕËٶȳ£Êý,absorption rate constantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ð×÷±ê¶¨,collaborative studyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç×ÓÒ©Àú,Electronic medication recordÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÔàÍ´¾õ¹ýÃô,visceral hyperalgesiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢¿×ÉøÍ¸±Ã,micro-porous osmotic pumpÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁòËáÎ÷Ë÷Ã×ÐÇ,sisomicin sulfateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿çĤתÔË,transmembrane transportÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏõËáë¹ûÜ¿Ïã¼î,Pilocarpine nitrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥Ïò¶¯×÷µçλ,Monophasic action potentialÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËá°¢ÆËÂð·È,apomorphine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
SAS³ÌÐò,SAS programÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ßɰ±ÍÐÃÀÍ¡,amtolmetin guacylÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
N-Vµ°°×ø,N-V proteinaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À×ÄÎËáïÈ,strontium ranelateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×é°·ÊÜÌå,Histamine receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓñȪÍè,Yuquan PillÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÇÌú»¯ºÏÎï,ferrous compoundsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÞÁ¿¼ì²é,limit testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÉ«ËØP4502C9,cytochrome P450 2C9Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËá¼ÓÌæÉ³ÐÇ,Gatifloxacin hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏûºÄ½ð¶î,consumptive amount of moneyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á×Ëá¸ÆË®Äà,Calcium phosphate cementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àëÄ¿¹ÉúËØ,peptide antibioticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ú¼Ò»ù±¾Ò©ÎïÕþ²ß,National essential drug policyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹ÌÇÄò²¡»îÐÔ,antidiabetic activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈýάÔ×Ó³¡È«Ï¢×÷ÓÃʸÁ¿,three-dimensional holographic vector of atomic interaction field(3D-HoVAIF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÄѪ¹Ü¶¾ÐÔ,cardiovascular toxicityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚõ¥ÐÍ,lactone formÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Â½ÚÂÉ,beta rhythmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒæÉú×¢ÉäÒº,Yisheng injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¯Ì¬±È×Ç·¨,kinetic turbidimetric assayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´«µÝϵͳ,delivery systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
c-mycÔ°©»ùÒò,c-myc oncogeneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ȱ¸Æ,calcium deficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¨ËáÀà,Cholic acidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹°¬×̲¡¶¾»îÐÔ,anti-HIV activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏàËÆÒò×Ó·¨,similarity factor methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÍâ¿¹Õæ¾ú»îÐÔ,in vitro antifungal activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×¢²á¹ÜÀí,registration managementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TNF-¦ÁmRNA,TNF-¦Á mRNAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÍâÒ©ÎïÊÍ·Å,Drug release in vitroÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©Æ·µ÷¼Á,Drug dispensingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç»¯Ñ§¼ì²â·¨,electrochemical detectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÜѪ¶È,hemolytic degreeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÉ«ËØb5,Cytochrome b5Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Æ»ùÒòÏà¹ØëÄ,Calcitonin gene-related peptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáàÄÇÆÕÀû,quinapril hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉøÍ¸±Ã¿ØÊÍÆ¬,osmotic pump controlled release tabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ä£Ðͺ¯Êý,Model functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
P-Ìǵ°°×ÒÖÖÆ¼Á,P-glycoprotein inhibitorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
XaÒò×Ó,Factor XaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒâʶÏûʧ,Loss of consciousnessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÛÍ´Ä£ÐÍ,pain modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ç⻯¿ÉµÄËÉ×¢ÉäÒº,Hydrocortisone injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦Æ½»¬¼¡,intestinal smooth muscleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ØÊÍϵͳ,controlled release systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºìÃ¹ËØ»·11,12-̼Ëáõ¥,Erythromycin cyclic 11,12-carbonateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ßÉÂØËáÄÆ,sodium gualenateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¿¿¹´Æ¼¤ËØ,Pure antiestrogenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿Úǻճ¸½Æ¬,Buccal adhesive tabletÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TTC·¨,TTC methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏßÐÔ¶¯Ì¬·¶Î§,Linear dynamic rangeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³É±¾Ô¼Êø,cost constraintÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÕÈûЧӦ,plugging effectÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò©Îﰲȫ,drug safetyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½ºÊøµç¶¯Ã«Ï¸¹ÜµçÓ¾,micellar electrokinetic capillary chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹âÏË´«¸Ðϵͳ,optical fiber sensing systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÖÂÛ·¨,Discussion MethodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞÖ¸Å̳ôÍÜ,Odorrana grahamiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¯Ñ§Ô¤·À¼Á,chemopreventive agentsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÛ»¯µã,melting pointÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹Çò³æ»îÐÔ,anticoccidial activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËáÐÔ½µ½â,acid degradationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ¾ú¼ì²é·¨,sterility testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÖº¦Ê¼þ,disaster eventÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÅÏ¢¼ìË÷ÓëÀûÓÃ,information retrieval and utilizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|